By Kiran Mazumdar Shaw A healthy India is a wealthy India. For an emerging economic superpower, health of its people is critical for economic productivity. Ayushman Bharat, which recently completed a year of existence, was conceptualised as an insurance based, healthcare delivery model that dovetails both preventive and curative healthcare at a coverage of Rs … Continue reading Blueprint for a healthy India: Ayushman Bharat must tackle several challenges if it is to deliver tangible health benefits on scale
Balancing Patient Convenience with Environmental Protection
Kiran Mazumdar –Shaw, CMD Biocon There are nearly half a billion diabetes patients in the world today and by 2040 that number is expected to climb to over 640 million. Even as diabetes incidence grows across the globe, developed markets like the U.S. are grappling with astronomical prices of one of the key medications for … Continue reading Balancing Patient Convenience with Environmental Protection
My address to Biocon Women Employees on International Women’s Day 2019
Today, as the first women employee of Biocon, I celebrate a lot of things done right at Biocon in last 40 years. When I started Biocon in 1978, there were very few women keen in business space. I was perhaps the first tech startup in India because IT came to India a little later after … Continue reading My address to Biocon Women Employees on International Women’s Day 2019
From Brewing to Biologics: Kiran Mazumdar-Shaw in conversation with Catherine Jewell, Communications Division, WIPO
Kiran Mazumdar-Shaw shares with Catherine Jewell, her story of innovation and entrepreneurship; Her journey from brewing to creating Biocon, Asia's leading Biopharmaceutical Company.
A Journey of Endurance
By Kiran Mazumdar Shaw, CMD, Biocon The approval of our biosimilar Trastuzumab by the U.S. FDA is a vindication of our two-decade-long biologics-led pharmaceutical journey. We had invested ‘ahead of the curve’ in the promising future of targeted biologics at the turn of the millennium. At that time, we had anticipated some of the risks, … Continue reading A Journey of Endurance
India To Be A Biotech Hot Spot
The last 70 years have been transformational for the Indian biotech industry, mirroring the nation’s own rapidly advancing economy and rising global status. We have successfully leveraged recombinant DNA technology to deliver biopharmaceuticals, vaccines, genetically engineered crops and enzymes. In doing so, we have created a notable bio-economy valued at $35 billion. We have embraced … Continue reading India To Be A Biotech Hot Spot
Healing the World
To download the complete article, visit: http://bit.ly/2ncVkXM
Biocon Advances In War Against Diabetes
There are nearly half a billion diabetes patients in the world. The alarming growth in the global diabetes population is leading to a huge demand for effective therapies from pre/early diabetes to late-stage disease. Of the 100 million people who need insulin globally, however, only ‘one in two’ can manage and afford costs associated with … Continue reading Biocon Advances In War Against Diabetes
A Collaborative Approach to Healthcare Delivery
The highest attainable standard of health is a fundamental right of every human being. In this context, universal access to healthcare assumes prime importance. However, healthcare delivery poses a significant challenge for policymakers in India. A severe lack of resources means that there is only one doctor per 1,700 citizens in India, well below the … Continue reading A Collaborative Approach to Healthcare Delivery
Ensuring World Class Affordable Cancer Care
This video captures the highlights of the daylong NDTV Fortis CANCERTHON campaign telecasted on Sunday, Feb 8th, 2015. The initiative, focused on creating awareness on Cancer and raising funds to support treatment of children suffering with Cancer. This video talks about the affordable Cancer Care model at the Mazumdar Shaw Cancer Centre. Kiran Mazumdar Shaw … Continue reading Ensuring World Class Affordable Cancer Care